Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

INmune Bio Inc. - Common stock (NQ:INMB)

2.090 -0.220 (-9.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,811,868
Open 2.090
Bid (Size) 2.070 (2)
Ask (Size) 2.090 (13)
Prev. Close 2.310
Today's Range 1.890 - 2.220
52wk Range 1.890 - 11.64
Shares Outstanding 17,703,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From INmune Bio, Inc.
Via GlobeNewswire

Performance

YTD
-57.6%
-57.6%
1 Month
-70.9%
-70.9%
3 Month
-73.2%
-73.2%
6 Month
-55.1%
-55.1%
1 Year
-75.2%
-75.2%

More News

Read More
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Crude Oil Moves Lower; Joby Aviation Shares Surge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Which stocks are moving on Monday?
Via Chartmill
Alzheimer's Setback Hits INmune Bio Stock, But FDA Hopes Remain
Via Benzinga
Dow Gains Over 100 Points; Chicago PMI Weakens In June
Via Benzinga
Topics Stocks
Gapping stocks in Monday's session
Via Chartmill
INmune Bio Stock Slumps After Alzheimer’s Drug Falls Short In Mid-Stage Trial
Via Stocktwits
Get insights into the top gainers and losers of Monday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease
From INmune Bio, Inc.
Via GlobeNewswire
Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Stock Soars Friday On Alzheimer's Treatment Hopes
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
INmune Bio Skyrockets After-Hours On Alzheimer’s Trial Buzz; Retail Bulls Bet Big Before Data Reveal Next Week
Via Stocktwits
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
Via Chartmill
INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
From INmune Bio, Inc.
Via GlobeNewswire
XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense
From INmune Bio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is INmune Bio Inc. - Common stock publicly traded?
Yes, INmune Bio Inc. - Common stock is publicly traded.
What exchange does INmune Bio Inc. - Common stock trade on?
INmune Bio Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for INmune Bio Inc. - Common stock?
The ticker symbol for INmune Bio Inc. - Common stock is INMB on the Nasdaq Stock Market
What is the current price of INmune Bio Inc. - Common stock?
The current price of INmune Bio Inc. - Common stock is 2.090
When was INmune Bio Inc. - Common stock last traded?
The last trade of INmune Bio Inc. - Common stock was at 07/01/25 04:00 PM ET
What is the market capitalization of INmune Bio Inc. - Common stock?
The market capitalization of INmune Bio Inc. - Common stock is 37.00M
How many shares of INmune Bio Inc. - Common stock are outstanding?
INmune Bio Inc. - Common stock has 37M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.